Growth Metrics

Cumberland Pharmaceuticals (CPIX) Other financing activities (2016 - 2022)

Cumberland Pharmaceuticals' Other financing activities history spans 13 years, with the latest figure at -$370464.0 for Q1 2022.

  • On a quarterly basis, Other financing activities fell 232.3% to -$370464.0 in Q1 2022 year-over-year; TTM through Mar 2022 was -$650484.0, a 147.35% decrease, with the full-year FY2019 number at $1.0 million, up 1121.21% from a year prior.
  • Other financing activities hit -$370464.0 in Q1 2022 for Cumberland Pharmaceuticals, up from -$632646.0 in the prior quarter.
  • Over the last five years, Other financing activities for CPIX hit a ceiling of $1.0 million in Q3 2019 and a floor of -$806390.0 in Q4 2020.
  • Historically, Other financing activities has averaged $70521.5 across 5 years, with a median of $131692.0 in 2020.
  • The widest YoY moves for Other financing activities: up 1057.1% in 2019, down 422.44% in 2019.
  • Tracing CPIX's Other financing activities over 5 years: stood at $81886.0 in 2018, then soared by 1057.1% to $947500.0 in 2019, then tumbled by 185.11% to -$806390.0 in 2020, then grew by 21.55% to -$632646.0 in 2021, then skyrocketed by 41.44% to -$370464.0 in 2022.
  • Business Quant data shows Other financing activities for CPIX at -$370464.0 in Q1 2022, -$632646.0 in Q4 2021, and $452536.0 in Q3 2021.